Literature DB >> 20082249

Effects of Danggui Buxue Decoction () on lipid peroxidation and MMP-2/9 activities of fibrotic liver in rats.

Yuan Chen1, Qian Chen, Jing Lu, Feng-hua Li, Yan-yan Tao, Cheng-hai Liu.   

Abstract

OBJECTIVE: To explore the mechanism of Danggui Buxue Decoction (, DBD) on the liver fifibrosis related to hepatic lipid peroxidation and matrix metalloproteinases (MMP) -2/9 activities.
METHODS: The liver fifibrosis in 28 rats was induced by an injection of carbon tetrachloride (CCl(4)) and fed with high lipid and low protein diet for 6 weeks, the model rats were randomly divided into the model group and DBD treated group, 14 in each group, and another 10 rats as the normal group were observed as well. Rats in the DBD group were administered with DBD at the dose of 6 g/kg body weight for 6 weeks since CCl(4) intoxication. The hepatic inflammation and fibrosis were examined with HE and Sirius red stain. The liver function including serum alanine aminotransamine (ALT), aspartate transamine (AST), albumin (Alb) and total bilirubin (TBIL), liver triglyceride (TG) and malondialdehyde (MDA) contents, superoxide dismutase (SOD) activity were assayed. Hepatic hydroxyproline (Hyp) content was detected with Jamall's method. The alpha-SMA expression was analyzed by immunohistochemistry and the Western blot. Liver MMP-2 mRNA was analyzed with Real-time PCR, and MMP-2/9 activities were measured with gelatin zymography and in situ zymography.
RESULTS: Compared with the normal group, the levels of ALT, AST and TBIL, the content of Hyp, TG and MDA were remarkably increased, the Alb content and SOD activity were signifificantly decreased in the model group (P<0.05), and higher levels of MMP-2 mRNA and MMP-2/9 activities (P<0.01), the hepatic fatty degeneration and collagen accumulation and fifibrosis at liver were observed. Compared with the model control, DBD group showed slighter hepatic fatty degeneration and collagen deposition, and had lower levels of ALT, AST and TBIL activities, lower contents of MDA, TG and Hyp, but higher SOD level and Alb content (P<0.05), and DBD also down-regulated MMP-2 mRNA expression and decreased MMP-2/9 activities in the fifibrotic livers (P<0.01).
CONCLUSION: The action of DBD against liver fibrosis is related to prevent lipid peroxidation and inhibit MMP-2/9 activities in the fibrotic livers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082249     DOI: 10.1007/s11655-009-0435-y

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  11 in total

Review 1.  Oxidative stress-related molecules and liver fibrosis.

Authors:  M Parola; G Robino
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

Review 2.  Pathogenesis of liver fibrosis: role of oxidative stress.

Authors:  G Poli
Journal:  Mol Aspects Med       Date:  2000-06

3.  [Guidelines for the diagnosis and treatment of liver fibrosis in integrative medicine practice].

Authors: 
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2006-11

4.  Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.

Authors:  B Wielockx; K Lannoy; S D Shapiro; T Itoh; S Itohara; J Vandekerckhove; C Libert
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

5.  Quantitative zymography: detection of picogram quantities of gelatinases.

Authors:  D E Kleiner; W G Stetler-Stevenson
Journal:  Anal Biochem       Date:  1994-05-01       Impact factor: 3.365

6.  A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues.

Authors:  I S Jamall; V N Finelli; S S Que Hee
Journal:  Anal Biochem       Date:  1981-03-15       Impact factor: 3.365

7.  Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.

Authors:  Scott L Friedman; Don C Rockey; D Montgomery Bissell
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

Review 8.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

9.  Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.

Authors:  S Milani; H Herbst; D Schuppan; C Grappone; G Pellegrini; M Pinzani; A Casini; A Calabró; G Ciancio; F Stefanini
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

10.  Verification of the formulation and efficacy of Danggui Buxue Tang (a decoction of Radix Astragali and Radix Angelicae Sinensis): an exemplifying systematic approach to revealing the complexity of Chinese herbal medicine formulae.

Authors:  Qiutao Gao; Jun Li; Jerry Ka Hei Cheung; Jinao Duan; Anwei Ding; Anna Wing Han Cheung; Kuijun Zhao; Winnie Zhuoming Li; Tina Tingxia Dong; Karl Wah Keung Tsim
Journal:  Chin Med       Date:  2007-11-29       Impact factor: 5.455

View more
  11 in total

1.  A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo.

Authors:  Tao Guo; Zu-Long Liu; Qiang Zhao; Zhi-Min Zhao; Cheng-Hai Liu
Journal:  Acta Pharmacol Sin       Date:  2018-05-31       Impact factor: 6.150

Review 2.  Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine.

Authors:  Yuewen Gong
Journal:  Chin J Integr Med       Date:  2012-03-30       Impact factor: 1.978

Review 3.  The Latest Research Advances of Danggui Buxue Tang as an Effective Prescription for Various Diseases: A Comprehensive Review.

Authors:  Chen-Chen Ma; Yue-Hua Jiang; Yan Wang; Rui-Rong Xu
Journal:  Curr Med Sci       Date:  2022-10-17

4.  Effect of heat stress and recovery on viability, oxidative damage, and heat shock protein expression in hepatic cells of grass carp (Ctenopharyngodon idellus).

Authors:  Yanting Cui; Bo Liu; Jun Xie; Pao Xu; H-Michael Habte-Tsion; Yuanyuan Zhang
Journal:  Fish Physiol Biochem       Date:  2013-10-18       Impact factor: 2.794

Review 5.  A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect.

Authors:  Tung-Ting Sham; Chi-On Chan; You-Hua Wang; Jian-Mei Yang; Daniel Kam-Wah Mok; Shun-Wan Chan
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

6.  Danggui buxue tang inhibits 2,4-dinitrochlorobenzene: induced atopic dermatitis in mice.

Authors:  Li-Wen Fang; Chao-Chun Cheng; Tzann-Shun Hwang; Wen-Chung Huang; Chian-Jiun Liou; Wen-Chyuan Chen; Shu-Ju Wu
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-10       Impact factor: 2.629

7.  Traditional Chinese medicine Danggui Buxue Tang inhibits colorectal cancer growth through induction of autophagic cell death.

Authors:  Shun-Ting Chen; Tzung-Yan Lee; Tung-Hu Tsai; Yu-Chuen Huang; Yin-Cheng Lin; Chin-Ping Lin; Hui-Ru Shieh; Ming-Ling Hsu; Chih-Wen Chi; Ming-Cheng Lee; Hen-Hong Chang; Yu-Jen Chen
Journal:  Oncotarget       Date:  2017-08-03

8.  Astragaloside IV Synergizing with Ferulic Acid Ameliorates Pulmonary Fibrosis by TGF-β1/Smad3 Signaling.

Authors:  Jiahuan Tong; Zhisong Wu; Yuchen Wang; Qingxun Hao; Haoge Liu; Fang Cao; Yang Jiao
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-02       Impact factor: 2.629

9.  The chinese herbal decoction danggui buxue tang inhibits angiogenesis in a rat model of liver fibrosis.

Authors:  Jing Lv; Zhimin Zhao; Yuan Chen; Qinglan Wang; Yanyan Tao; Li Yang; Tai-Ping Fan; Chenghai Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-29       Impact factor: 2.629

Review 10.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.